Functional restoration of exhausted CD4+ and CD8+ T cells in chronic viral infection by vinegar-processed flos of Daphne genkwa

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 39, Issue , 2015, Pages 25-37

  Uyangaa, Erdenebileg ^a   Choi, Jin Young ^a   Patil, Ajit Mahadev ^a   Kim, Jin Hyoung ^a   Kim, Seong Bum ^a   Kim, Koanhoi ^b   Ryu, Hyung Won ^c   Oh, Sei Ryang ^c   Eo, Seong Kug ^a  

^a Chonbuk National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Chronic viral infection; Daphne genkwa; Exhausted T cells; Tim 3 molecule; Vinegar processed flos

Indexed keywords

CELL PROTEIN; HERBACEOUS AGENT; PROGRAMMED DEATH 1 RECEPTOR; TIM 3 PROTEIN; UNCLASSIFIED DRUG; ACETIC ACID; HAVCR2 PROTEIN, MOUSE; PLANT MEDICINAL PRODUCT; TUMOR NECROSIS FACTOR ALPHA; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM IDENTIFICATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STRESS; CHRONIC DISEASE; CONTROLLED STUDY; DAPHNE; DAPHNE GENKWA; DOWN REGULATION; DRUG DETERMINATION; DRUG RESPONSE; DRUG SCREENING; GROWTH INHIBITION; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS LOAD; ANIMAL; ARENAVIRIDAE INFECTIONS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; FLOWER; IMMUNOLOGY; METABOLISM; PHYTOTHERAPY;

DAPHNE GENKWA; FLOS; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

ACETIC ACID; ANIMALS; ARENAVIRIDAE INFECTIONS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DAPHNE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FLOWERS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; PHYTOTHERAPY; PLANT PREPARATIONS; RECEPTORS, VIRUS; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

EID: 84925781124     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2015.02.001     Document Type: Article

References (46)

1. Williams M.A., Bevan M.J. Effector and memory CTL differentiation. Annu Rev Immunol 2007, 25:171-192.
2. + T cell differentiation during viral infection. Immunity 2007, 27:393-405.
3. Wherry E.J. T cell exhaustion. Nat Immunol 2011, 12:492-499.
4. Kulinski J.M., Tarakanova V.L., Verbsky J. Regulation of antiviral CD8 T-cell responses. Crit Rev Immunol 2013, 33:477-488.
5. + T cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev 2010, 238:247-262.
6. McKinstry K.K., Strutt T.M., Swain S.L. Hallmarks of CD4 T cell immunity against influenza. J Intern Med 2011, 269:507-518.
7. + cytotoxic T cell responses during chronic viral infection. J Virol 1994, 68:8056-8063.
8. + T cell-deficient mice. J Virol 1994, 68:4700-4704.
9. Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J.D., Suresh M., Altman J.D., et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998, 188:2205-2213.
10. + T cells upon acute versus persistent viral infection. Immunity 1998, 9:449-457.
11. Brooks D.G., Teyton L., Oldstone M.B., McGavern D.B. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J Virol 2005, 16:10514-10527.
12. Blattman J.N., Greenberg P.D. Cancer immunotherapy: a treatment for the masses. Science 2004, 305:200-205.
13. Ho W.Y., Blattman J.N., Dossett M.L., Yee C., Greenberg P.D. Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction. Cancer Cell 2003, 3:431-437.
14. Palucka K., Ueno H., Banchereau J. Recent developments in cancer vaccines. J Immunol 2011, 186:1325-1331.
15. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
16. + T cell exhaustion during chronic viral infection. Immunity 2007, 27:670-684.
17. + T cell dysfunction in melanoma patients. J Exp Med 2010, 207:2175-2186.
18. Sakuishi K., Apetoh L., Sullivan J.M., Blazar B.R., Kuchroo V.K., Anderson A.C. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 2010, 27:2187-2194.
19. Brahmer J.R., Drake C.G., Wollner I., Powderly J.D., Picus J., Sharfman W.H., et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 2010, 28:3167-3175.
20. + T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009, 10:29-37.
21. Jones R.B., Ndhlovu L.C., Barbour J.D., Sheth P.M., Jha A.R., Long B.R., et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008, 205:2763-2779.
22. Jin H.T., Anderson A.C., Tan W.G., West E.E., Ha S.J., Araki K., et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A 2010, 107:14733-14738.
23. Wherry E.J., Blattman J.N., Murali-Krishna K., Most R., Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 2003, 77:4911-4927.
24. Gallimore A., Glithero A., Godkin A., Tissot A.C., Pluckthun A., Elliott T., et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med 2010, 187:1383-1393.
25. Matloubian M., Kolhekar S.R., Somasundaram T., Ahmed R. Molecular and determinants of macrophages tropism and viral persistence: importance of single amino acid changes in the polymerase glycoprotein of lymphocytic choriomeningitis virus. J Virol 2003, 67:7340-7349.
26. Jiangsu New Medical College The Encyclopedia of traditional Chinese medicine 1985, 2573. Shanghai Science and Technology, Shanghai. 2nd ed.
27. Zhan Z.J., Fan C.Q., Ding, Yue J.M. Novel diterpenoids with potent inhibitory activity against endothelium cell HMEC and cytotoxic activities from a well-known TCM plant Daphne genkwa. Bioorg Med Chem 2005, 13:645-655.
28. Hall I.H., Liou Y.F., Oswald C.B., Lee K.H. The effects of genkwadaphnin and gnidiladitin on the growth of P-388, L-1210 leukemia and KB carcinoma cells in vitro. Eur J Cancer Clin Oncol 1986, 22:45-52.
29. Huai S.C.R., Yu D.F., Wu X.G. Studies on the anti-fertility constituent of the flower yuan-hua isolation and structure of yuanhuatine. Huaxue Xuebao 1985, 43:460-461.
30. Park B.Y., Min B.S., Oh S.R., Kim J., Bae K.H., Lee H.K. Isolation of flavonoids, a biscoumarin and an amide from the flower buds of Daphe genkwa and the evolution of their anti-complement activity. Phytother Res 2006, 20:610-613.
31. Geng L., Sun H., Yuan Y., Liu Z.Z., Cui Y., Bi K.S., et al. Discrimination of raw and vinegar-processed Genkwa Flos using metabolomics coupled with multivariate data analysis: a discrimination study with metabolomics coupled with PCA. Fitoterapia 2013, 84:286.
32. + T cells with diverse cytokines profiles. Nat Med 2005, 11:1113-1120.
33. Aubert R.D., Kamphorst A.O., Sarkar S., Vezys V., Ha S.J., Barber D.L., et al. Antigen-specific CD4 T-cell helps rescues exhausted CD8 T cells during chronic viral infection. Proc Natl Acad Sci U S A 2011, 108:21182-21187.
34. Rudolph M.G., Stanfield R.L., Wilson I.A. How TLRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 2006, 24:419-466.
35. Svitek N., Hansen A.M., Steinaa L., Saya R., Awino E., Nielsen M., et al. Use of 'one-pot, mix-and-read' peptide-MHC class I tetramers and predictive algorithms to improve detection of cytotoxic T lymphocyte responses in cattle. Vet Res 2014, 45:50.
36. + T cells response with major histocompatibility complex pentamers in kidney transplant recipients. Transplant Proc 2011, 43:2336-2340.
37. Dolton G., Lissina A., Skowera A., Ladell K., Tungatt K., Lones E., et al. Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells. Clin Exp Immun 2014, 177:47-63.
38. + T cell responses by CD154 expression. Nat Protoc 2006, 1:1-6.
39. + regulatory T cells by MHC class II tetramer and intracellular CD154 staining. Immune Netw 2013, 6:264-274.
40. Park B.Y., Min B.S., Ahn K.S., Kwon O.K., Joung H., Bae K.H., et al. Daphnane diterpene esters isolated from flower buds of Daphne genkwa induce apoptosis in human myelocytic HL-60 cells and suppress tumor growth in Lewis lung carcinoma (LLC)-inoculated mouse model. J Ethnopharmacol 2007, 111:496-503.
41. Fuller M.J., Callendret B., Zhu B., Freeman G.J., Hasselschwert D.L., Satterfield W., et al. Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1). Proc Natl Acad Sci U S A 2013, 110:15001-15006.
42. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
43. + T cells and regulates Th1 and Th17 cytokines. Eur J Immunol 2009, 39:2492-2500.
44. Zhu C., Anderson A.C., Schuhart A., Xiong H., Imitola J., Khoury S.J., et al. The TIM-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005, 6:1245-1250.
45. Sabatos C.A., Chakravarti S., Cha E., Schubart A., Sauchez-Fueyo, Zheng X.X., et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 2003, 4:1102-1110.
46. Sanchez-Fucyo A., Tian J., Picarella D., Domenig C., Zheug X.X., Sabatos C.A., et al. Tim-3 inhibits T helper type 1 mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003, 4:1093-1100.